Silverfin false false 31/03/2026 08/01/2025 31/03/2026 Dr. A Badakhsh 08/01/2025 22 April 2026 The principal activity of the Company during the financial year is that of developing innovative hydrogen and ammonia technologies. SC833448 2026-03-31 SC833448 bus:Director1 2026-03-31 SC833448 core:CurrentFinancialInstruments 2026-03-31 SC833448 core:ShareCapital 2026-03-31 SC833448 core:OtherResidualIntangibleAssets 2025-01-07 SC833448 2025-01-07 SC833448 core:OtherResidualIntangibleAssets 2026-03-31 SC833448 core:OtherPropertyPlantEquipment 2025-01-07 SC833448 core:OtherPropertyPlantEquipment 2026-03-31 SC833448 bus:OrdinaryShareClass1 2026-03-31 SC833448 2025-01-08 2026-03-31 SC833448 bus:FilletedAccounts 2025-01-08 2026-03-31 SC833448 bus:SmallEntities 2025-01-08 2026-03-31 SC833448 bus:AuditExemptWithAccountantsReport 2025-01-08 2026-03-31 SC833448 bus:PrivateLimitedCompanyLtd 2025-01-08 2026-03-31 SC833448 bus:Director1 2025-01-08 2026-03-31 SC833448 core:OtherResidualIntangibleAssets core:TopRangeValue 2025-01-08 2026-03-31 SC833448 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-08 2026-03-31 SC833448 core:OtherPropertyPlantEquipment core:TopRangeValue 2025-01-08 2026-03-31 SC833448 core:OtherResidualIntangibleAssets 2025-01-08 2026-03-31 SC833448 core:OtherPropertyPlantEquipment 2025-01-08 2026-03-31 SC833448 bus:OrdinaryShareClass1 2025-01-08 2026-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC833448 (Scotland)

ENTROPYST LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 08 JANUARY 2025 TO 31 MARCH 2026
PAGES FOR FILING WITH THE REGISTRAR

ENTROPYST LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 08 JANUARY 2025 TO 31 MARCH 2026

Contents

ENTROPYST LTD

BALANCE SHEET

AS AT 31 MARCH 2026
ENTROPYST LTD

BALANCE SHEET (continued)

AS AT 31 MARCH 2026
Note 31.03.2026
£
Fixed assets
Intangible assets 3 4,436
Tangible assets 4 862
5,298
Current assets
Cash at bank and in hand 574
574
Creditors: amounts falling due within one year 5 ( 5,871)
Net current liabilities (5,297)
Total assets less current liabilities 1
Net assets 1
Capital and reserves
Called-up share capital 6 1
Total shareholder's funds 1

For the financial period ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Entropyst Ltd (registered number: SC833448) were approved and authorised for issue by the Director on 22 April 2026. They were signed on its behalf by:

Dr. A Badakhsh
Director
ENTROPYST LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 08 JANUARY 2025 TO 31 MARCH 2026
ENTROPYST LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 08 JANUARY 2025 TO 31 MARCH 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Entropyst Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Inspire Hub 6th Floor, Graham Hills Building, 50 Richmond St, Glasgow, G1 1XU, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The reporting period covers 15 months from incorporation on 8 January 2025 until the company's financial period end of 31 March 2026.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 10 years straight line
Trademarks, patents and licences

Separately acquired patents are included at cost and amortised in equal annual instalments over a period of 10 years which is their estimated useful economic life. Provision is made for any impairment.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

Period from
08.01.2025 to
31.03.2026
Number
Monthly average number of persons employed by the Company during the period, including the director 2

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 08 January 2025 0 0
Additions 4,511 4,511
At 31 March 2026 4,511 4,511
Accumulated amortisation
At 08 January 2025 0 0
Charge for the financial period 75 75
At 31 March 2026 75 75
Net book value
At 31 March 2026 4,436 4,436

4. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 08 January 2025 0 0
Additions 880 880
At 31 March 2026 880 880
Accumulated depreciation
At 08 January 2025 0 0
Charge for the financial period 18 18
At 31 March 2026 18 18
Net book value
At 31 March 2026 862 862

5. Creditors: amounts falling due within one year

31.03.2026
£
Other creditors 5,871

6. Called-up share capital

31.03.2026
£
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1

7. Related party transactions

Transactions with the entity's director

31.03.2026
£
Amounts owed to directors 290

These amounts are unsecured, interest free and have no fixed repayment terms